B

DividendsBioNexus Gene Lab

BGLC

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
9/28/2023
10/13/2023
0,165
Quarterly
6/29/2023
7/13/2023
0,165
Quarterly
3/30/2023
4/13/2023
0,165
Quarterly
12/29/2022
1/13/2023
0,165
Quarterly
9/29/2022
10/14/2022
0,165
Quarterly
6/29/2022
7/14/2022
0,165
Quarterly
3/30/2022
4/14/2022
0,165
Quarterly